Implications of structural and functional brain changes in amyotrophic lateral sclerosis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2018-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14737175.2018.1464912PMID 29667443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)

  2018cited by this paper
• Stem cells for ALS: An overview of possible therapeutic approaches

  2017cited by this paper
• Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study

  2017cited by this paper
• Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity

  2017cited by this paper
• Motor neurone disease: progress and challenges

  2017cited by this paper
• Cortical influences drive amyotrophic lateral sclerosis

  2017cited by this paper
• Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis

  2016cited by this paper
• Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis

  2016cited by this paper
• Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk

  2016cited by this paper
• Amyotrophic lateral sclerosis: moving towards a new classification system

  2016cited by this paper
• Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS

  2016cited by this paper
• Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS

  2016cited by this paper
• The frontotemporal dementia-motor neuron disease continuum.

  2016cited by this paper
• Treatment approaches in motor neurone disease.

  2016cited by this paper
• Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis

  2016cited by this paper
• What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?

  2015cited by this paper
• Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28

  2015cited by this paper
• Functional overlap and divergence between ALS and bvFTD.

  2015cited by this paper
• Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies.

  2015cited by this paper
• ALFF Value in Right Parahippocampal Gyrus Acts as a Potential Marker Monitoring Amyotrophic Lateral Sclerosis Progression: a Neuropsychological, Voxel-Based Morphometry, and Resting-State Functional MRI Study

  2015cited by this paper
• Distinct patterns of cortical atrophy in ALS patients with or without dementia: An MRI VBM study

  2014cited by this paper
• Cortical thickness in ALS: towards a marker for upper motor neuron involvement

  2014cited by this paper
• Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis

  2014cited by this paper
• Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes.

  2014cited by this paper
• Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.

  2014cited by this paper
• The phenotypic variability of amyotrophic lateral sclerosis

  2014cited by this paper
• Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum

  2014cited by this paper
• Glial-restricted precursors as potential candidates for ALS cell-replacement therapy.

  2014cited by this paper
• Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

  2014influential reference
• Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

  2014cited by this paper
• Multimodal tract-based analysis in ALS patients at 7T: A specific white matter profile?

  2014cited by this paper
• Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis

  2014cited by this paper
• Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

  2013cited by this paper
• The involvement of the cerebellum in amyotrophic lateral sclerosis

  2013cited by this paper
• Multiparametric MRI study of ALS stratified for the C9orf72 genotype

  2013influential reference
• Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72

  2013cited by this paper
• of amyotrophic lateral sclerosis

  2013cited by this paper
• Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis

  2013cited by this paper
• Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness

  2013cited by this paper
• Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997–2011

  2013cited by this paper
• Divergent brain network connectivity in amyotrophic lateral sclerosis.

  2013cited by this paper
• 25 years of neuroimaging in amyotrophic lateral sclerosis

  2013cited by this paper
• Motor and extramotor neurodegeneration in amyotrophic lateral sclerosis: A 3T high angular resolution diffusion imaging (HARDI) study

  2013cited by this paper
• Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study

  2013influential reference
• Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis

  2012cited by this paper
• Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality

  2012influential reference
• Upper motor and extra-motor neuron involvement in recent-onset motor neuron disease

  2012influential reference
• Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum

  2012cited by this paper
• Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

  2012cited by this paper
• Amyotrophic lateral sclerosis.

  2012cited by this paper
• Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?

  2012cited by this paper
• Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights

  2012cited by this paper
• Neuroimaging in amyotrophic lateral sclerosis.

  2012cited by this paper
• Structural and functional evaluation of cortical motor areas in Amyotrophic Lateral Sclerosis.

  2012cited by this paper
• Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.

  2011cited by this paper
• Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging.

  2011cited by this paper
• Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis.

  2011cited by this paper
• Cognitive Functions and White Matter Tract Damage in Amyotrophic Lateral Sclerosis: A Diffusion Tensor Tractography Study

  2011cited by this paper
• The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

  2011cited by this paper
• White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis.

  2011cited by this paper
• Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis.

  2011cited by this paper
• Impaired Structural Motor Connectome in Amyotrophic Lateral Sclerosis

  2011cited by this paper
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

  2011cited by this paper
• Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis

  2011influential reference
• Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia

  2011cited by this paper
• Clinical diagnosis and management of amyotrophic lateral sclerosis

  2011cited by this paper
• EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases

  2010cited by this paper
• Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis

  2010cited by this paper
• MR Spectroscopy Findings in Early Stages of Motor Neuron Disease

  2010cited by this paper
• Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis

  2010cited by this paper
• Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis

  2010cited by this paper
• The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Registration based cortical thickness measurement

  2009cited by this paper
• ALS motor phenotype heterogeneity, focality, and spread

  2009cited by this paper
• Biomarkers in Amyotrophic Lateral Sclerosis

  2009cited by this paper
• Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.

  2008cited by this paper
• Diffusion-based tractography in neurological disorders: concepts, applications, and future developments.

  2008cited by this paper
• Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis

  2007cited by this paper
• Quantitative objective markers for upper and lower motor neuron dysfunction in ALS

  2007cited by this paper
• Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.

  2007cited by this paper
• Hyperintensity of the precentral gyral subcortical white matter and hypointensity of the precentral gyrus on fluid-attenuated inversion recovery: variation with age and implications for the diagnosis of amyotrophic lateral sclerosis.

  2007cited by this paper
• Consistent resting-state networks across healthy subjects

  2006cited by this paper
• Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy.

  2006cited by this paper
• Frontotemporal white matter changes in amyotrophic lateral sclerosis

  2005cited by this paper
• A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD

  2005cited by this paper
• Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

  2005influential reference
• Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)

  2004cited by this paper
• Cortical selective vulnerability in motor neuron disease: a morphometric study.

  2004cited by this paper
• Reduced NAA in motor and non‐motor brain regions in amyotrophic lateral sclerosis: a cross‐sectional and longitudinal study

  2004influential reference
• Clinical applications of diffusion tensor imaging

  2004influential reference
• Reversible diffusion MRI abnormalities and transient mutism after liver transplantation

  2004cited by this paper
• Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis.

  2004cited by this paper
• The Underpinnings of the BOLD Functional Magnetic Resonance Imaging Signal

  2003cited by this paper
• Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

  2003cited by this paper
• Amyotrophic lateral sclerosis: Objective upper motor neuron markers

  2002cited by this paper
• Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

  2001cited by this paper
• Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings

  2001cited by this paper

• The role of serum vitamins in mediating the effect of neurodegenerative diseases on subcortical brain volume

  2025cites this paper
• In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI study

  2025cites this paper
• Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics.

  2024cites this paper
• From Skin and Gut to the Brain: The Infectious Journey of the Human Commensal Fungus Malassezia and Its Neurological Consequences

  2024cites this paper
• Evolving markers in amyotrophic lateral sclerosis.

  2023cites this paper
• Differential cortical gray matter changes in early- and late-onset patients with amyotrophic lateral sclerosis.

  2023cites this paper
• Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

  2021cites this paper
• Behavioural changes predict poorer survival in amyotrophic lateral sclerosis.

  2021cites this paper
• Cortical Excitability across the ALS Clinical Motor Phenotypes

  2021cites this paper
• Brain Cortical Complexity Alteration in Amyotrophic Lateral Sclerosis: A Preliminary Fractal Dimensionality Study

  2020cites this paper
• Transcranial magnetic stimulation in the cortical exploration of dementia

  2020cites this paper
• Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

  2020cites this paper
• The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis

  2020cites this paper
• Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis

  2020cites this paper
• Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices.

  2019cites this paper
• Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis

  2018cites this paper